Clinical Trial Update: TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for TAC-101 in advanced hepatocellular carcinoma, reporting Phase 1 and Phase 2 results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cancer

Drugs mentioned

• TAC-101

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Liver Cancer | Phase 1, Phase 2 | Status: COMPLETED